跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-QUETIAPINE TABLET 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-QUETIAPINE TABLET 25MG
Approved
THERAPEUTIC
APO-QUETIAPINE TABLET 25MG
APOTEX INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 25, 2013
Approval ID
0be125dcb3506986
Company
APOTEX INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
0be125dcb3506986
Drug Name
APO-QUETIAPINE TABLET 25MG
Product Name
APO-QUETIAPINE TABLET 25MG
Approval Number
SIN14342P
Approval Date
2013-04-25
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N05AH04
Atc Item Name
quetiapine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
QUETIAPINE FUMARATE 28.77MG EQV QUETIAPINE
25MG
QUETIAPINE FUMARATE 28.77 MG EQV QUETIAPINE
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 25, 2013
Approval ID
0be125dcb3506986
Type
Therapeutic
Back to HSA Approvals